.Pfizer in talks with China for to market COVID-19 antiviral treatment: Report
China's drug and medical devices regulator, the National Medical Products Administration, has been in talks with Pfizer to manufacture and distribute generic versions of Paxlovid since last month, according to Reuters.
Paxlovid was found to reduce the risk of hospitalization and death by 89% for unvaccinated people with COVID-19 at higher risk for severe disease, per the Centers for Disease Control and Prevention.China has been experiencing an outbreak of cases that first started in December as it departs from its"zero COVID" policies that conducted mass testing campaigns and forced millions into lockdowns since the start of the pandemic.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
China Covid: WHO warns about under-representing Covid deathsThe health body says it is worried about the risk to life and again urges Beijing for better data.
Les mer »
As COVID vaccine and Paxlovid sales decline, analysts want to know what's next for PfizerPfizer is the latest pandemic stock to face questions about its long-term strategy as revenue from its COVID-19 vaccine and antiviral business starts to dry up.
Les mer »
World's largest iPhone factory back to 90% capacity in China: ReportThe world's largest iPhone factory in Zhengzhou, China, has resumed 90% capacity after being shut down for months due to the government's zero-COVID policies.
Les mer »
Blockade of Taiwan by China could cost world economy over $2 trillion, report findsA report by the Rhodium Group estimates that a blockade of Taiwan by China could cause a 'catastrophic' disruption of more than $2 trillion in global economic activity.
Les mer »
White House hopeful war with China over Taiwan 'never comes to pass': reportWhite House National Security Adviser Jake Sullivan said he believes war with China over Taiwan can be avoided even as tensions remain high in the region.
Les mer »